Progestagen-dependent effect on some plasma proteins during oral contraception

Area of Science:

• Endocrinology
• Pharmacology
• Reproductive Health

Background:

• Oral contraceptives (OCs) are widely used for birth control.
• Different OC formulations may have varying effects on hormone-binding proteins.
• Understanding these effects is crucial for assessing the safety and efficacy of OCs.

Purpose of the Study:

• To compare the effects of two different oral contraceptive formulations on serum levels of specific proteins.
• To investigate the impact of ethinyl estradiol combined with levonorgestrel versus desogestrel on sex hormone binding globulin, transcortin, ceruloplasmin, and pregnancy-associated protein.

Main Methods:

• A 2-year prospective study involving 17 healthy women using oral contraception.
• Two OC formulations were tested: ethinyl estradiol/levonorgestrel and ethinyl estradiol/desogestrel.
• Serum protein levels were measured at baseline, various intervals during treatment, and after cessation.

Main Results:

• Both OC formulations significantly increased serum ceruloplasmin and pregnancy-associated protein levels.
• Ethinyl estradiol-desogestrel significantly elevated sex hormone binding globulin levels, unlike ethinyl estradiol-levonorgestrel.
• Transcortin levels increased with both preparations, with a more pronounced rise observed with ethinyl estradiol-desogestrel.

Conclusions:

• Both ethinyl estradiol-levonorgestrel and ethinyl estradiol-desogestrel oral contraceptives induce significant changes in certain serum proteins.
• The ethinyl estradiol-desogestrel combination demonstrates a greater impact on sex hormone binding globulin and transcortin compared to ethinyl estradiol-levonorgestrel.
• These findings highlight formulation-specific differences in the endocrine effects of oral contraceptives.